20523 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof
#1802Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide
#1803Vaporized medicants and methods of use
#1804Method for preparing herbal composition having increased fat-solublepolyphenol content, herbal composition prepared thereby and use thereof
#1805Chemicals and methods to prevent and treat TGF-beta mediated activation of fibroblasts to reduce and treat cancer and fibrosis
#1806PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1807COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES
#1808Methods of screening and treatment with USP4 inhibitors
#1809DIAGNOSIS AND TREATMENT OF INVASIVE ASPERGILLOSIS
#1810TOPICAL ANTIFUNGAL PASTES AND METHODS OF USE THEREOF
#1811Sulfur(VI) fluoride compounds and methods for the preparation thereof
#1812COSMETIC AND PHARMACEUTICAL FOAM
#1813Composition comprising an algal proteoglycan extract and use thereof
#1814Methods for solid tumor treatment
#1815Polyphenol-reactive oxygen species compositions and methods
#1816Biomembrane, closed structure with biomembrane characteristics or cellular compartment derived from natural sources and/or self-assembly techniques, preparation method and applications thereof
#1817Treatment and Prevention of Bone and Joint Disorders
#1818Methods for treating infection including sepsis via P2X receptor modulation
#1819PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1820Formulations of 5-fluorocytosine and uses thereof
#1821Antifungal Compositions
#1822Treatment and prevention of joint disorders
#1823PDE III inhibitors for treatment of asymptomatic heart failure
#1824Agent for preventing and/or treating Alzheimer's disease
#1825COMBINATIONS OF OPIOID RECEPTOR LIGANDS AND CYTOCHROME P450 INHIBITORS
#1826EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME
#1827Container assembly
#1828Use of carrimycin in infection resistance
#1829DIETARY SUPPLEMENTS AND FORMULATIONS
#1830DIETARY SUPPLEMENTS AND FORMULATIONS
#1831Composition, containing Loganin or a derivative thereof as an active ingredient for preventing, remedying, or treating female climacteric syndrome
#1832COMPOSITIONS COMPRISING 4'-O-GLUCURONIDE EPICATECHIN AND METHODS OF MAKING AND USING SUCH COMPOSITIONS
#1833COMPOUNDS, COMPOSITIONS AND METHODS FOR PROTECTING BRAIN HEALTH IN NEURODEGENERATIVE DISORDERS
#1834Tumor therapeutic agent
#1835Methods of diagnosing and treating infected implants
#1836Proteasome modulation for treatment of corneal disorders
#1837Method of ameliorating side effects of sickle cell disease treatments
#1838COMBINATION OF A CARDIAC STEROID AND AN AKT INHIBITOR FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS
#1839Therapeutic method and therapeutic agent for atopic dermatitis in animals
#1840METHODS FOR TREATING RESISTANT DISEASES USING TRIAZOLE CONTAINING MACROLIDES
#1841Biomarkers for predicting infection treatment outcome
#1842Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof
#1843HSPC-sparing treatments for Rb-positive abnormal cellular proliferation
#1844Transient protection of normal cells during chemotherapy
#1845Pharmaceutical compositions comprising clofazimine analog compound B746 or clofazimine analog compound B826
#1846Animal treatments
#1847Methods for administering weight loss medications
#1848Methods of preventing or treating filovirus and flavivirus diseases
#1849Compositions and methods using a polyphenol for musculoskeletal health
#1850Uses of DPP IV inhibitors
#1851Composition containing Oroxylin A and method of extraction thereof
#1852Probiotic recolonisation therapy
#1853Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea
#1854METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS
#1855Complex of a glucopyranosyl derivative and preparation method and use thereof
#1856DRUG FOR PREVENTING AND TREATING ALOPECIA
#1857Nanoparticles for treatment of posterior segment ocular diseases and conditions
#1858PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1859USE OF ENZYME-MODIFIED ISOQUERCITRIN
#1860Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
#1861COMPOSITIONS FOR ANTI-INFLAMMATORY, ANTIOXIDANT EFFECTS AND IMPROVED RESPIRATORY FUNCTION BY SPECIFIC HISTONE DEACETYLASE INHIBITION
#1862Use of cannabinoids in the treatment of epilepsy
#1863SOLID PHARMACEUTICAL DOSAGE FORM FOR RELEASE OF AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT IN THE ORAL CAVITY
#1864Compositions for delivery of drug combinations
#1865Composition for ameliorating loss of hair and graying of hair, and use thereof
#1866USE OF PAEONIFLORIN-6'-O-BENZENESULFONATE IN TREATMENT OF SJÖGREN'S SYNDROME
#1867Antifungal agents used in combination
#1868Co-crystals and pharmaceutical compositions comprising the same
#1869Methods and pharmaceutical compostions for treating rhabdomyolysis
#1870Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne
#1871Methods of inhibiting the virulence of a pathogen with an oxidized tannin to treat a gastrointestinal spasm
#1872Compositions and methods of treating acne and photoaging
#1873Therapy for inhibition of single-stranded RNA virus replication
#1874PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1875SNS-595 AND METHODS OF USING THE SAME
#1876Methods for treating pulmonary non-tuberculous mycobacterial infections
#1877Combination therapy for treating malignancies
#1878Oral dissolving films
#1879Specific nutritional or therapeutic agent including a mixture of grape and blueberry
#1880Pharmaceutical Composition for Treating STK11-Mutation Cancer Using Cardiac Glycosides
#1881Combination therapy for treating malignancies
#1882Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
#1883Inhibition of multiple pathogenic agents using bithionol
#1884Compositions for treating heart disease by inhibiting the action of mAKAP-β
#1885Process for preparing a composition comprising a high concentration of one or more avermectins
#1886Compositions and methods for invasive and non-invasive procedural skincare
#1887Process for preparing a stable emulsion comprising one or more avermectins
#1888Oligonucleotides for modulating gene expression and uses thereof
#1889Formulation for targeting cancer in humans and canines using chlorotoxin
#1890Formulation for targeting cancer in humans and canines using venom
#1891Combination of opioids and anticancer drugs for cancer treatment
#1892LIPOSOME INCLUDING TAXANE COMPOUND
#1893Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
#1894COMPOSITIONS AND METHODS FOR PARKINSON'S DISEASE THERAPY
#1895Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones
#1896Combination therapy for EV71 infection
#1897Treatment of papulopustular rosacea with ivermectin
#1898COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF METABOLIC SYNDROME
#1899Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
#1900Restoring physiology in iron-deficient organisms using small molecules
#1901SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE
#1902Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
#1903AQUEOUS DRUG DELIVERY SYSTEM
#1904Method of making solanaceae fruit extracts
#1905Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms
#1906Method of using a composition in the treatment of obesity
#1907Composition of trigofoenoside and flavonoids and methods thereof
#1908Edible composition
#1909Antiviral supplement formulations
#1910ANTIFUNGAL AND ANTIPARASITIC POLYENE MACROLIDES
#1911Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
#1912Forazolines, compositions thereof and uses thereof
#1913External dermal agent for reducing yellowish dullness
#1914Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head Lice
#1915Flavonoid compositions and related methods
#1916Compositions and methods for increasing energy metabolism
#1917Compounds and methods for treating an epileptic disorder
#1918Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent
#1919METHODS AND KITS FOR SELECTING TREATMENT FOR ORAL INFECTIONS
#1920PHARMACEUTICAL COMPOSITION, SUBSTRATE COMPRISING A PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION
#1921DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#1922Intraluminal therapy system for gastrointestinal infections
#1923SSTR-targeted conjugates and particles and formulations thereof
#1924Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
#1925Transient protection of normal cells during chemotherapy
#1926Method of treating insomnia
#1927ANTIMICROBIALS AND METHODS OF USE THEREOF FOR WOUND HEALING
#1928COSMETIC AND PHARMACEUTICAL FOAM
#1929Composition for preventing and treating osteoporosis, comprising dihydrophaseic acid 3′-O-β-D-glucopyranoside isolated from lycium root bark extracts
#1930NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
#1931METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#1932Method for relieving memory dysfunction using Puerariae radix extract
#1933TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
#1934Composition for optic nerve protection
#1935NON-MECHANICAL PROCESS FOR THE MICRONIZATION OF DIGOXIN
#1936Pharmaceutical composition, methods for treating and uses thereof
#1937Therapeutic agent for myotonic dystrophy
#1938Antiviral Activity from Medicinal Mushrooms and Their Active Constituents
#1939Application of naringenin and naringin in tumor radiotherapy
#1940STABILIZED HIGH DRUG LOAD NANOCARRIERS, METHODS FOR THEIR PREPARATION AND USE THEREOF
#1941CHEWABLE COMPOSITION COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT
#1942System, retainer and method of preventing and treating nosocomial infections including methicillin-resistant infections
#1943PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1944Compositions for reducing appetite and craving, increasing satiety, enhancing mood, and reducing stress
#1945Dosage regimen for a tiacumicin compound
#1946Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
#1947Targeted structure-specific particulate delivery systems
#1948Cochleates made with soy phosphatidylserine
#1949Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
#1950Use of pimobendan for the reduction of heart size in mammals suffering from heart failure
#1951PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF
#1952COMPOSITIONS AND METHODS FOR INHIBITING LEISHMANIA
#1953Pharmaceutical compositions
#1954Methods and devices for treating a retinal detachment
#1955Milk-derived microvesicle compositions and related methods
#1956TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
#1957METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT
#1958Microspheres containing anthelmintic macrocyclic lactones
#1959GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS
#1960COMPOSITIONS AND METHODS FOR USING LAMELLAR BODIES FOR THERAPEUTIC PURPOSES
#1961PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#1962COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS
#1963Vaporized medicants and methods of use
#1964Antibiotic sensitivity-restoring and photosensitive agents
#1965USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO ANTI-MICROBIAL AGENTS
#1966LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#1967METHODS AND ASSAYS FOR COMBINATION TREATMENT OF CANCER
#1968Acylated glucagon analogues
#1969Shape memory particles for biomedical uses
#1970Compositions, kits and methods for treating type II diabetes mellitus
#1971Methods of treating a treatment-resistant gastrointestinal spasm with an oxidized tannin
#1972PLANT-BASED BIOLOGICALLY ACTIVE SUBSTANCE HAVING A POLYPHARMACOLOGICAL EFFECT
#1973METHOD AND COMPOSITION FOR CRUDE FORMULATIONS OF FORTIFIED SUGAR FOR GLYCEMIC CONTROL
#1974THERAPEUTIC COMPOSITION
#1975ORAL ADMINISTRATION OF ANTHOCYANINS, ANTHOCYANIDINS, AND THEIR METABOLITES FOR THE TREATMENT OF INFLAMMATION IN AN INFLAMMED JOINT
#1976Targeting microRNAs for the treatment of liver cancer
#1977Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
#1978Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
#1979Analogues of etoposide for the treatment of tumours
#1980Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine
#1981Combination therapies for treating cancer
#1982Pharmaceutical compounding methods and systems
#1983Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#1984FXR agonist compositions for combination therapy
#1985Methods and compositions for preventing or treating fatty liver, protecting liver function or ameliorating liver diseases caused by fatty liver or other associated disorders
#1986METHOD, SYSTEM AND APPARATUS FOR CONTROLLED DELIVERY OF OPIOID AND OTHER MEDICATIONS
#1987Enteric combination therapy
#1988COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES ASSOCIATED WITH ACTIVATED T CELLS AND/OR B CELLS
#1989COMPOSITION FOR SUPPRESSING MUSCULAR FATTY CHANGE
#1990METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION
#1991PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
#1992Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine
#1993Antimicrobials and methods of use thereof for wound healing
#1994LIQUID COMPOSITIONS CAPABLE OF FOAMING AND INCLUDING ACTIVE AGENTS, AND METHODS FOR MAKING OR DEVELOPING SAME
#1995Acylated glucagon analogue
#1996Composition for amelioration of peri- and post-menopausal symptoms and a process for producing the same
#1997Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-ascorbic acid
#1998Pharmaceutical compositions containing clofazimine for inhibiting activity
#1999Antimicrobials and methods of use thereof
#2000Antimicrobials and methods of use thereof for wound healing
#2001ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES
#2002STING (Stimulator of Interferon Genes), A Regulator of Innate Immune Responses
#2003Method to improve safety and efficacy of anti-cancer therapy
#2004Targeting fungi in combination with cancer therapy
#2005USE OF DIANHYDROGALACTITOL OR DERIVATIVES OR ANALOGS THEREOF FOR TREATMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM MALIGNANCIES
#2006Antimicrobials and methods of use thereof
#2007Pharmaceutical Oral Dose Formulation and Composition of Matter
#2008Skin Solution with Solubilized Bakuchiol
#2009Compositions for use in the treatment of tumors resistant to chemotherapy
#2010PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#2011Compositions and methods for nucleic acid transfer
#2012Compounds from invasive Salvinias and methods of using the same
#2013Control release of fat soluble antioxidants from an oral formulation and method
#2014NUTRITIONAL COMPOSITIONS AND ASSOCIATED METHODS
#2015Antimicrobials and methods of use thereof
#2016Siderophore-polymer conjugates for increasing bacterial sensitivity to antibiotics
#2017Extended-release topiramate capsules
#2018RUFINAMIDE AND DERIVATIVES AND THEIR USE IN MODULATING THE GATING PROCESS OF HUMAN VOLTAGE-GATED SODIUM CHANNELS
#2019Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye
#2020Traditional Chinese medicine composition for treating prostate cancer, preparation method and application thereof
#2021Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations
#2022Method of treating neurological conditions with extract of species or species
#2023Etoposide and prodrugs thereof for use in targeting cancer stem cells
#2024Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
#2025Method of improving lacrimal secretion for dry eye treatment using maqui berry extract
#2026Composition and method for treating acute respiratory tract infections
#2027PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
#2028Multivitamin capable of beneficial gene regulation through microRNA (miRNA)
#2029Quinazolinone antibiotics
#2030Composition for preventing, alleviating or treating burnout syndrome
#2031Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2032Treatment of diseases using combination of ultraviolet blood irradiation and antibiotics
#2033Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndrome
#2034Stable antibacterial composition
#2035Pharmaceutical compositions
#2036Compound from the avermectin family for treating and/or preventing folliculitis
#2037Compounds and compositions for improving power output and oxygen efficiency
#20385HT agonists for treating disorders
#2039Process for the fractionation of seeds from oleaginous plants
#2040METHOD FOR MANUFACTURING DRUG-CONTAINING BIODEGRADABLE FIBER MATERIAL BY ELECTROSPINNING
#2041Compositions for enhancing brain activity
#2042EUCOMMIA LEAF EXTRACT, AND PREPARATION METHOD AND USE THEREOF
#2043WATER-SOLUBLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE AND AT LEAST ONE SUBSTANCE CAPABLE OF FORMING MICELLES
#2044Methods and compositions for unsilencing imprinted genes
#2045POLYAPHRONS AND PALPEBRAL ADMINISTRATION THEREOF
#2046RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS
#2047METHODS AND COMPOSITIONS FOR UPREGULATING ENDOGENOUS ANTIOXIDANT SYSTEMS
#2048ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS OR PRECURSORS THEREOF
#2049Furoquinolinediones as inhibitors of TDP2
#2050METHODS AND COMPOSITIONS FOR REDUCING DAMAGE ASSOCIATED WITH OXIDATIVE PHOSPHORYLATION
#2051Methods and compositions for supporting endogenous systems related to life span
#2052Pesticidal active mixtures comprising isoxazoline compounds I
#2053FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
#2054Method of treating pain using agents that promote neuronal differentiation
#2055Methods of treating a treatment-resistant gastrointestinal spasm
#2056STABLE FORMULATIONS FOR THE ORAL ADMINISTRATION OF AMPHOTERICIN B AND RELATED METHODS
#2057Method of treating neurological conditions with oleandrin
#2058SNS-595 AND METHODS OF USING THE SAME
#2059CYCLODEXTRIN-BASED POLYMERS FOR DELIVERING THE THERAPEUTIC AGENTS COVALENTLY BOUND THERETO
#2060CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
#2061Methods and materials for reducing the risk of infections
#2062COMPOSITION FOR PREVENTING OR TREATING COLITIS
#2063Treatment of filarial diseases
#2064PHARMACEUTICAL COMPOSITION COMPRISING TOPIRAMATE
#2065PAEONIFLORIN PREPARATIONS AND USES THEREOF FOR FAT REDUCTION
#2066TREATMENT OF EARLY STAGE PARKINSON'S DISEASE WITH A HYDROXYTYROSOL-CONTAINING POLYPHENOL FORMULATION
#2067Methods of treating and prognosing nonhematopoietic malignant tumors
#2068Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
#2069PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING AN HYDROUS CRYSTALLINE 2-O-ALPHA-D-GLUCOSYL-L-ASCORBIC ACID
#2070Methods for treating pulmonary non-tuberculous mycobacterial infections
#2071Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells
#2072ANTHELMINTHIC MACROLIDE SYNTHESIS
#2073Crystalline isoxazole hydroxamic acid compounds
#2074Treatment of rhinosinusitis with P-glycoprotein inhibitors
#2075FORMULATION
#2076NEW C-GLYCOSYLPOLYPHENOL ANTIDIABETIC AGENTS, EFFECT ON GLUCOSE TOLERANCE AND INTERACTION WITH BETA-AMYLOID. THERAPEUTIC APPLICATIONS OF THE SYNTHESIZED AGENT(S) AND OF GENISTA TENERA ETHYL ACETATE EXTRACTS CONTAINING SOME OF THOSE AGENTS
#2077COMPOSITIONS AND METHOD OF USE OF A-TYPE PROCYANIDINS
#2078An Antimicrobial Composition
#2079Compositions and methods for treating autism spectrum disorders
#2080Food supplement for restoring male sex drive (libido)
#2081COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#2082PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#2083Compositions and methods for treating an infection
#2084Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
#2085Compositions and Methods for Treating an Infection
#2086Amphotericin B derivatives
#2087INHIBITION OF NONSENSE MEDIATED MRNA DECAY BY DRUGS THAT PREVENT HYPUSINATION OF EUKARYOTIC INITIATION FACTOR 5A
#2088Tissue and cell stain formula with a novel molecule obtained from Papaver Rhoeas
#2089Methods of increasing fertility of a male subject with costus speciosus extract
#2090Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
#2091TRANSDERMAL PARASITICIDAL FORMULATIONS
#2092Binding molecules, especially antibodies, binding to L1CAM (CD171)
#209314-membered ketolides and methods of their preparation and use
#2094PARENTERAL COMPOSITIONS AND USES THEREOF
#2095METHODS FOR TREATING AND PREVENTING MUCOSITIS
#2096Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis
#2097METHODS OF INCREASING SOLUBILITY OF POORLY SOLUBLE COMPOUNDS AND METHODS OF MAKING AND USING FORMULATIONS OF SUCH COMPOUND
#2098SIRTUIN GENE POTENTIATOR, AND PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AND FOOD PRODUCT USING SAME
#2099METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING MUCOSITIS
#2100Methods and compositions for increasing the potency of antifungal agents